bilirubinemia


Also found in: Dictionary, Medical.
Related to bilirubinemia: bilirubinuria

bilirubinemia

[¦bil·ə‚rü·bə′nē·mē·ə]
(medicine)
The presence of bilirubin in the blood.
McGraw-Hill Dictionary of Scientific & Technical Terms, 6E, Copyright © 2003 by The McGraw-Hill Companies, Inc.
References in periodicals archive ?
The global percentage of patients who achieved the bilirubinemia target was 37.9%.
In the severe hyper- bilirubinemia group the time between jaundice first being noticed by the families and admission to hos- pital was longer.
(1997) Assessing liver function hyper bilirubinemia in the new born.
The animals had leucocytosis, anemia, bilirubinemia, hypoproteinemia and elevated aspartate amino transferase, alanine aminotransferase and alkaline phosphatase.
Hemoglobinuria (not hematuria), unconjugated bilirubinemia (3.35 mg%), elevated LDH (491 U/L), normal vitamin B12 (439 pg/mL), and normal folic acid (13.24 ng/mL) were noted; therefore, her macrocystosis (MCV: 106.7 fL) was considered to be associated with her marked reticulocytosis.
It is mainly used for obtaining fast information on the bilirubin concentration in neonatal hyper bilirubinemia.
Effects of bilirubinemia, hemolysis, and lipemia on clinical chemistry analytes in bovine, canine, equine, and feline sera.
(18) Activation of Kuppfer cells may lead to symptoms of liver damage often observed during sepsis, including bilirubinemia and elevated liver enzymes.
In our study group 4% of patients had only indirect bilirubinemia suggesting haemolysis and 27.1% patients had raised liver enzymes indicative of "malarial hepatitis" due to direct hepatic injury by the parasite.
Laboratory studies found leukopenia, increased total bilirubinemia liver enzymes, prolonged prothrombin time (PT), serum amylase and lipase within normal limits, negative anti-dengue fever IgM serology and positive hepatitis A IgM serology (using The Abbott Axsym microparticle enzyme immunoassay method).
Frequently Reported Adverse Events Over 3 Years in the BENEFIT Study Early Treatment, Delayed Treatment, n = 292 n = 176 Adverse Event n (%) n (%) Injection-site reactions 158 (54.1) 68 (38.6) Influenza-like symptoms 144 (49.3) 86 (48.9) Headache 95 (32.5) 50 (28.4) Upper respiratory tract infection 97 (29.8) 53 (30.1) Asthenia 77 (26.4) 48 (27.3) Paresthesia 76 (26.0) 46 (26.1) Leucopenia 69 (23.6) 23 (13.1) Depression 52 (17.8) 36 (20.5) Fever 47 (16.1) 18 (10.2) Back pain 44 (15.1) 19 (10.8) Rash 43 (14.7) 16 (9.1) Pharyngitis 43 (14.7) 24 (13.6) Insomnia 32 (11.0) 18 (10.2) Myalgia 29 (9.9) 18 (10.2) Bilirubinemia 27 (9.6) 18 (10.2) Aspartate aminotransferase increased 33 (11.3) 8 (4.5) Alanine aminotransferase increased 46 (15.8) 12 (6.8) Note.
Repeat screening is recommended when a child is readmitted to a NICU or well infant nursery with a condition associated with hearing loss, such as hypertension, bilirubinemia that requires exchange transfusion, and culture-positive sepsis.